The Tuberculosis Vaccine Initiative (TBVI) and the International AIDS Vaccine Initiative (IAVI) have updated the TB Vaccine Development Pathway.
This online tool provides a structured development path and gating criteria for TB vaccine candidates, and may be useful for any vaccine development. In addition to TB specific considerations and target populations, the updated Pathway now includes vaccine technologies and community engagement, and expands on market, access and implementation.
For more information, read the official announcement here.
Source: TBVI